Drug Development Lags for Neglected Diseases

Of the 850 new drugs and vaccines approved for all diseases over the past decade, only 37 were for so-called neglected diseases: malaria, TB, chagas, sleeping sickness and other diseases of poverty. A new study published in The Lancet Global Health highlights what its authors call a 'fatal imbalance' in research and development of treatments for the world's poorest patients.   Neglected diseases — prevalent primarily in poor countries — account for more than 11 percent of the ...

© La Voix de l'Amérique - jeudi 24 octobre 2013